117 related articles for article (PubMed ID: 37697452)
1. Limited Sampling Strategies for Estimating Busulfan Area Under the Concentration-Time Curve: Based on Peak and Trough Concentrations in Saliva.
Xu B; Zhou J; Zheng Y; Xu R; Liu Q; Li D; Liu M; Wu X
J Clin Pharmacol; 2024 Jan; 64(1):58-66. PubMed ID: 37697452
[TBL] [Abstract][Full Text] [Related]
2. Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration-time curve in pediatric hematopoietic stem cell transplant recipients.
Watanabe E; Nishikawa T; Ikawa K; Yamaguchi H; Abematsu T; Nakagawa S; Kurauchi K; Kodama Y; Tanabe T; Shinkoda Y; Matsumoto K; Okamoto Y; Takeda Y; Kawano Y
Int J Hematol; 2015 Nov; 102(5):611-6. PubMed ID: 26243625
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of Imatinib Mesylate and Development of Limited Sampling Strategies for Estimating the Area under the Concentration-Time Curve of Imatinib Mesylate in Palestinian Patients with Chronic Myeloid Leukemia.
Adawi DH; Fredj NB; Al-Barghouthi A; Dridi I; Lubada M; Manasra M; Aouam K
Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):43-55. PubMed ID: 38006575
[TBL] [Abstract][Full Text] [Related]
4. Limited sampling strategy for predicting busulfan exposure in hematopoietic stem cell transplantation recipients.
Huang JJ; Chen B; Hu J; Yang WH
Int J Clin Pharm; 2017 Aug; 39(4):662-668. PubMed ID: 28555420
[TBL] [Abstract][Full Text] [Related]
5. IV busulfan dose individualization in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
Dupuis LL; Sibbald C; Schechter T; Ansari M; Gassas A; Théorêt Y; Kassir N; Champagne MA; Doyle J
Biol Blood Marrow Transplant; 2008 May; 14(5):576-82. PubMed ID: 18410900
[TBL] [Abstract][Full Text] [Related]
6. Two-point blood sampling is sufficient and necessary to estimate the area under the concentration-time curve for intravenous busulfan in infants and young children.
Utano T; Kato M; Sakamoto K; Osumi T; Matsumoto K; Tomizawa D; Matsumoto K; Yamatani A
Pediatr Blood Cancer; 2021 Aug; 68(8):e29069. PubMed ID: 33881202
[TBL] [Abstract][Full Text] [Related]
7. Saliva as a noninvasive sampling matrix for therapeutic drug monitoring of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation: A prospective population pharmacokinetic and simulation study.
Xu B; Yang T; Zhou J; Zheng Y; Wang J; Liu Q; Li D; Zhang Y; Liu M; Wu X
CPT Pharmacometrics Syst Pharmacol; 2023 Sep; 12(9):1238-1249. PubMed ID: 37491812
[TBL] [Abstract][Full Text] [Related]
8. A limited sampling strategy for pharmacokinetic directed therapy with intravenous busulfan.
Vaughan WP; Carey D; Perry S; Westfall AO; Salzman DE
Biol Blood Marrow Transplant; 2002; 8(11):619-24. PubMed ID: 12463481
[TBL] [Abstract][Full Text] [Related]
9. Limited Sampling Strategy for Accurate Prediction of Pharmacokinetics of Saroglitazar: A 3-point Linear Regression Model Development and Successful Prediction of Human Exposure.
Joshi SN; Srinivas NR; Parmar DV
Clin Ther; 2018 Mar; 40(3):456-468.e1. PubMed ID: 29496320
[TBL] [Abstract][Full Text] [Related]
10. Limited Sampling Strategies Supporting Individualized Dose Adjustment of Intravenous Busulfan in Children and Young Adults.
Teitelbaum Z; Nassar L; Scherb I; Fink D; Ring G; Lurie Y; Krivoy N; Bentur Y; Efrati E; Kurnik D
Ther Drug Monit; 2020 Jun; 42(3):427-434. PubMed ID: 31479045
[TBL] [Abstract][Full Text] [Related]
11. Accurate Prediction of Initial Busulfan Exposure Using a Test Dose With 2- and 6-Hour Blood Sampling in Adult Patients Receiving a Twice-Daily Intravenous Busulfan-Based Conditioning Regimen.
Huang J; Li Z; Liang W; Chen B; Hu J; Yang W
J Clin Pharmacol; 2019 May; 59(5):638-645. PubMed ID: 30512187
[TBL] [Abstract][Full Text] [Related]
12. Limited sampling strategy for predicting isoniazid exposure in patients with extrapulmonary tuberculosis.
Alshaikheid M; Chaabane A; Ben Fredj N; Ben Brahim H; Ben Fadhel N; Chadli Z; Slama A; Boughattas NA; Chakroun M; Aouam K
J Clin Pharm Ther; 2020 Jun; 45(3):503-512. PubMed ID: 31833581
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Robustness of Therapeutic Drug Monitoring Coupled with Bayesian Forecasting of Busulfan with Regard to Inaccurate Documentation.
Dadkhah A; Alihodzic D; Broeker A; Kröger N; Langebrake C; Wicha SG
Pharm Res; 2021 Oct; 38(10):1721-1729. PubMed ID: 34664209
[TBL] [Abstract][Full Text] [Related]
14. Test Dose Pharmacokinetics in Pediatric Patients Receiving Once-Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach?
Brooks KM; Jarosinski P; Hughes T; Kang E; Shah NN; Gall JBL; Hickstein DD; De Ravin SS; George JM; Kumar P
J Clin Pharmacol; 2018 Mar; 58(3):332-339. PubMed ID: 29238995
[TBL] [Abstract][Full Text] [Related]
15. Limited Sampling Strategy for the Estimation of Tacrolimus Area Under the Concentration-Time Curve in Chinese Adult Liver Transplant Patients.
Liu XX; Xu BM; Chen H; Song YY; Yang WH; Chen B
Pharmacology; 2016; 98(5-6):229-241. PubMed ID: 27449772
[TBL] [Abstract][Full Text] [Related]
16. Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.
Alffenaar JW; Kosterink JG; van Altena R; van der Werf TS; Uges DR; Proost JH
Ther Drug Monit; 2010 Feb; 32(1):97-101. PubMed ID: 20042919
[TBL] [Abstract][Full Text] [Related]
17. Validation of a 2-Point Limited Sampling Strategy to Predict the Tacrolimus Area-Under-the-12-Hour-Curve in Kidney Transplant Recipients.
Vadcharavivad S; Susomboon T; Kulabusaya B; Avihingsanon Y; Praditpornsilpa K; Townamchai N
Ther Drug Monit; 2016 Oct; 38(5):614-20. PubMed ID: 27328329
[TBL] [Abstract][Full Text] [Related]
18. Quantification of busulfan in saliva and plasma in haematopoietic stem cell transplantation in children : validation of liquid chromatography tandem mass spectrometry method.
Rauh M; Stachel D; Kuhlen M; Gröschl M; Holter W; Rascher W
Clin Pharmacokinet; 2006; 45(3):305-16. PubMed ID: 16509762
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Two Analytical Methods for Busulfan Therapeutic Drug Monitoring.
De Gregori S; Tinelli C; Manzoni F; Bartoli A
Eur J Drug Metab Pharmacokinet; 2021 Jan; 46(1):155-159. PubMed ID: 33231835
[TBL] [Abstract][Full Text] [Related]
20. Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.
Bartelink IH; Lalmohamed A; van Reij EM; Dvorak CC; Savic RM; Zwaveling J; Bredius RG; Egberts AC; Bierings M; Kletzel M; Shaw PJ; Nath CE; Hempel G; Ansari M; Krajinovic M; Théorêt Y; Duval M; Keizer RJ; Bittencourt H; Hassan M; Güngör T; Wynn RF; Veys P; Cuvelier GD; Marktel S; Chiesa R; Cowan MJ; Slatter MA; Stricherz MK; Jennissen C; Long-Boyle JR; Boelens JJ
Lancet Haematol; 2016 Nov; 3(11):e526-e536. PubMed ID: 27746112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
